将新型生物标志物整合到临床实践中:用于诊断和管理心脏病综合征的实际框架
Georgios Aletras1,2, Maria Bachlitzanaki2,3, Maria Stratinaki1
1Department of Cardiology, Venizelio General Hospital of Heraklion, 71409 Heraklion, Greece.
Life (Basel, Switzerland)
|October 29, 2025
概括
通过先进的生物标志物,心血管综合征 (CRS) 的管理得到改善. 新型标记器比传统测试提供更早的损伤检测和更好的风险分层,指导精确治疗.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 生物标志物研究 生物标志物研究
背景情况:
- 心脏综合征 (CRS) 涉及复杂的心脏相互作用,导致诊断挑战和患者的不良结果.
- 传统的生物标志物,如肌素和尿酸,在特异性和最佳CRS管理的时间上有局限性.
研究的目的:
- 审查心脏病综合征的既定和新兴生物标志物.
- 强调它们的临床相关性,将其纳入实践,以及精密治疗的潜力.
主要方法:
- 对CRS生物标志物的当前证据进行叙述性审查.
- 综合了已知和新型标志物的数据,包括GFR,管状损伤,拥堵,纤维化和炎症标志物.
- 讨论将生物标志物纳入临床决策的框架.
主要成果:
- 赛斯塔丁C在特定人群中提供了改进的GFR评估.
- 管管损伤标志物 (NGAL,KIM-1,L-FABP) 能够检测出早期的损伤.
- 尼弗罗查克® (TIMP-2/IGFBP7) 可以预测急性损伤 (AKI).
- 拥堵标记物 (CA125,生物上腺素) 和纤维化/炎症标记物 (银质素-3,sST2,GDF-15) 提供预后价值,特别是在NT-proBNP或上腺素.
结论:
- 基于多标志物和场景的方法提高了CRS的诊断精度和治疗安全性.
- 未来的研究应该专注于生物标志物引导的试验和改善CRS护理的临床整合途径.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
531
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
531
Chronic Kidney Disease III: Interprofessional Care
333
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
333
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
915
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
915
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
782
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
782
Chronic Kidney Disease IV: Nursing Management
312
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
312
Factors Affecting Renal Clearance: Renal Impairment
415
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
415


